Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Vistagen Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VTGN.
You can purchase shares of Vistagen Therapeutics (NASDAQ:VTGN) through any online brokerage.
Other companies in Vistagen Therapeutics’s space includes: Zura Bio (NASDAQ:ZURA), Cabaletta Bio (NASDAQ:CABA), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and TScan Therapeutics (NASDAQ:TCRX).
Vistagen Therapeutics has a consensus price target of $19.00.
The stock price for Vistagen Therapeutics (NASDAQ: VTGN) is $2.87 last updated March 24, 2025 at 7:23 AM EDT.
There are no upcoming dividends for Vistagen Therapeutics.
Vistagen Therapeutics’s Q4 earnings are confirmed for Tuesday, June 10, 2025.
There is no upcoming split for Vistagen Therapeutics.
Vistagen Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.